Targeting the tumor stroma with an oncolytic adenovirus secreting a fibroblast activation protein-targeted bispecific T-cell engager
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Targeting the tumor stroma with an oncolytic adenovirus secreting a fibroblast activation protein-targeted bispecific T-cell engager ; volume:7 ; number:1 ; day:25 ; month:1 ; year:2019 ; pages:1-15 ; date:12.2019
Journal for ImmunoTherapy of Cancer ; 7, Heft 1 (25.1.2019), 1-15, 12.2019
- Urheber
-
Sostoa, Jana de
Fajardo, Carlos Alberto
Moreno, Rafael
Ramos, Maria D.
Farrera-Sal, Martí
Alemany, Ramon
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40425-019-0505-4
- URN
-
urn:nbn:de:101:1-2019022723383979312516
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:45 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sostoa, Jana de
- Fajardo, Carlos Alberto
- Moreno, Rafael
- Ramos, Maria D.
- Farrera-Sal, Martí
- Alemany, Ramon
- SpringerLink (Online service)
Ähnliche Objekte (12)
Oncolytic adenovirus expressing bispecific antibody targets T‐cell cytotoxicity in cancer biopsies
Inducing expression of ICOS-L by oncolytic adenovirus to enhance tumor-specific bi-specific antibody efficacy
Non-secreting IL12 expressing oncolytic adenovirus Ad-TD-nsIL12 in recurrent high-grade glioma: a phase I trial
HSF1 overexpression enhances oncolytic effect of replicative adenovirus
Ixovex-1, a novel oncolytic E1B-mutated adenovirus
Establishing Suspension Cell Cultures for Improved Manufacturing of Oncolytic Adenovirus
Oncolytic viruses encoding bispecific T cell engagers: a blueprint for emerging immunovirotherapies
Targeting the Retinoblastoma/E2F repressive complex by CDK4/6 inhibitors amplifies oncolytic potency of an oncolytic adenovirus
Oncolytic adenovirus encoding LHPP exerts potent antitumor effect in lung cancer
Acetylcholinesterase overexpression mediated by oncolytic adenovirus exhibited potent anti-tumor effect
Effects of pre-existing anti-adenovirus antibodies on transgene expression levels and therapeutic efficacies of arming oncolytic adenovirus
Oncolytic adenovirus coding for shedding-resistant MICA enhances immune responses against tumors
Oncolytic adenovirus expressing bispecific antibody targets T‐cell cytotoxicity in cancer biopsies
Inducing expression of ICOS-L by oncolytic adenovirus to enhance tumor-specific bi-specific antibody efficacy
Non-secreting IL12 expressing oncolytic adenovirus Ad-TD-nsIL12 in recurrent high-grade glioma: a phase I trial
HSF1 overexpression enhances oncolytic effect of replicative adenovirus
Ixovex-1, a novel oncolytic E1B-mutated adenovirus
Establishing Suspension Cell Cultures for Improved Manufacturing of Oncolytic Adenovirus
Oncolytic viruses encoding bispecific T cell engagers: a blueprint for emerging immunovirotherapies
Targeting the Retinoblastoma/E2F repressive complex by CDK4/6 inhibitors amplifies oncolytic potency of an oncolytic adenovirus
Oncolytic adenovirus encoding LHPP exerts potent antitumor effect in lung cancer
Acetylcholinesterase overexpression mediated by oncolytic adenovirus exhibited potent anti-tumor effect
Effects of pre-existing anti-adenovirus antibodies on transgene expression levels and therapeutic efficacies of arming oncolytic adenovirus
Oncolytic adenovirus coding for shedding-resistant MICA enhances immune responses against tumors
Oncolytic adenovirus expressing bispecific antibody targets T‐cell cytotoxicity in cancer biopsies
Inducing expression of ICOS-L by oncolytic adenovirus to enhance tumor-specific bi-specific antibody efficacy
Non-secreting IL12 expressing oncolytic adenovirus Ad-TD-nsIL12 in recurrent high-grade glioma: a phase I trial
HSF1 overexpression enhances oncolytic effect of replicative adenovirus
Ixovex-1, a novel oncolytic E1B-mutated adenovirus
Establishing Suspension Cell Cultures for Improved Manufacturing of Oncolytic Adenovirus
Oncolytic viruses encoding bispecific T cell engagers: a blueprint for emerging immunovirotherapies
Targeting the Retinoblastoma/E2F repressive complex by CDK4/6 inhibitors amplifies oncolytic potency of an oncolytic adenovirus
Oncolytic adenovirus encoding LHPP exerts potent antitumor effect in lung cancer
Acetylcholinesterase overexpression mediated by oncolytic adenovirus exhibited potent anti-tumor effect
Effects of pre-existing anti-adenovirus antibodies on transgene expression levels and therapeutic efficacies of arming oncolytic adenovirus